DNA vaccine encoding human immunodeficiency virus-1 Gag, targeted to the major histocompatibility complex II compartment by lysosomal-associated membrane protein, elicits enhanced long-term memory response

Immunology

Volumn 112, Issue 1, 2004, Pages 126-135

  De Arruda, Luciana Barros ^a,b   Chikhlikar, Priya R ^b   August, J Thomas ^b   Marques, Ernesto T A ^b  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Immunological memory: T cell memory; MHC II: Trafficking; Vaccines: DNA LAMP Gag, prime boost immunizations

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; DNA VACCINE; GAG PROTEIN; MEMBRANE PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ANTIGEN DETECTION; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ARTICLE; B LYMPHOCYTE ACTIVATION; CHIMERA; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOLOGICAL MEMORY; LYMPHOCYTE ACTIVATION; LYSOSOME MEMBRANE; MAJOR HISTOCOMPATIBILITY COMPLEX; MEMORY CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; VACCINIA VIRUS;

AIDS VACCINES; ANIMALS; ANTIGENS, CD; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; GENE PRODUCTS, GAG; HISTOCOMPATIBILITY ANTIGENS CLASS II; HIV ANTIBODIES; HIV-1; IMMUNOLOGIC MEMORY; LYMPHOCYTE ACTIVATION; LYSOSOME-ASSOCIATED MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; VACCINES, DNA;

EID: 2342663201     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2004.01823.x     Document Type: Article

References (62)

1. Zinkernagel RM. On natural and artificial vaccinations. Annu Rev Immunol 2003; 21:515-46.
2. Kaech SM, Wherry EJ, Ahmed R. Effector and memory T-cell differentiation: implications for vaccine development. Nat Rev Immunol 2002; 2:251-62.
3. + T lymphocytes. Nature 2003; 421:852-6.
4. Shedlock DJ, Whitmire JK, Tan J, MacDonald AS, Ahmed R, Shen H. Role of CD4 T cell help and costimulation in CD8 T cell responses during Listeria monocytogenes infection. J Immunol 2003; 170:2053-63.
5. Shedlock DJ, Shen H. Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science 2003; 300:337-9.
6. Sun JC, Bevan MJ. Defective CD8 T cell memory following acute infection without CD4 T cell help. Science 2003; 300:339-42.
7. Bradley LM. CD4(+) cell memory: the enigma of Th1 cells. Trends Mol Med 2003; 9:186-8.
8. Barouch D, Santra S, Schmitz J et al. Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination. Science 2000; 290:486-92.
9. Amara R, Villinger F, Altman J et al. Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine. Science 2001; 292:69-74.
10. Iwasaki A, Torres CAT, Ohashi PS, Robinson HL. The dominant role of bone-marrow derived cells in CTL induction following plasmid DNA immunization at different sites. J Immunol 1997; 159:11-4.
11. Yewdell JW, Bennink JR. The binary logic of antigen processing and presentation to T cells. Cell 1990; 62:203-6.
12. Zhong G, Castellino F, Romagnoli P, Germain RN. Evidence that binding site occupancy is necessary and sufficient for effective major histocompatibility complex (MHC) class II transport through the secretory pathway redefines the primary function of class II-associated invariant chain peptides (CLIP). J Exp Med 1996; 184:2061-6.
13. Raviprakash K, Marques ETA, Ewing D et al. Synergistic neutralizing antibody response to a dengue virus type 2 DNA vaccine by incorporation of lysosome-associated membrane protein sequences and use of plasmid expressing GM-CSF. Virology 2001; 290:74-82.
14. Chan K, Lee DJ, Schubert A, Tang CM, Grain B, Schoenberger SP, Corr M. The roles of MHC class II, CD40, and B7 costimulation in CTL induction by plasmid DNA. J Immunol 2001; 166:3061-6.
15. Langlade-Demoyen P, Garcia-Pons F, Castiglioni P, Garcia Z, Cardinaud S, Xiong S, Gerloni M, Zanetti M. Role of T cell help and endoplasmic reticulum targeting in protective CTL response against influenza virus. Eur J Immunol 2003; 33:720-8.
16. Maecker HT, Umetsu DT, DeKruyff RH, Levy S. Cytotoxic T cell responses to DNA vaccination: dependence on antigen presentation via class II MHC. J Immunol 1998; 161:6532-6.
17. Guarnieri FG, Arterburn LM, Penno MB, Cha Y, August JT. The motif Tyr-X-X-hydrophobic residue mediates lysosomal membrane targeting of lysosome-associated membrane protein 1. J Biol Chem 1993; 268:1941-6.
18. Kleijmeer MJ, Morkowski S, Griffith JM, Rudensky AY, Geuze HJ. Major histocompatibility complex class II compartments in human and mouse B lymphoblasts represent conventional endocytic compartments. J Cell Biol 1997; 139:639-49.
19. Peters PJ, Neefjes JJ, Oorschot V, Ploegh HL, Geuze HJ. Segregation of MHC class II molecules from MHC class I molecules in the Golgi complex for transport to lysosomal compartments. Nature 1991; 349:669-76.
20. Geuze HJ. The role of endosomes and lysosomes in MHC class II functioning. Immunol Today 1998; 19:282-7.
21. Drake JR, Lewis TA, Condon KB, Mitchell RN, Webster P. Involvement of MIIC-like late endosomes in B cell receptor-mediated antigen processing in murine B cells. J Immunol 1999; 162: 1150-5.
22. Turley SJ, Inaba K, Garrett WS, Ebersold M, Unternaehrer J, Steinman RM, Mellman I. Transport of peptide-MHC class II complexes in developing dendritic cells. Science 2000; 288:522-7.
23. Lu Y, Raviprakash K, Leao IC et al. Dengue 2 PreM-E/LAMP chimera targeted to the MHC class II compartment elicits long-lasting neutralizing antibodies. Vaccine 2003; 21:2178-89.
24. Marques ET Jr, Chikhlikar P, De Arruda LB et al. HIV-1 p55Gag encoded in the lysosome-associated membrane protein-1 (LAMP-1) as a DNA plasmid vaccine chimera is highly expressed, traffics to MHC II compartment, and elicits enhanced immune responses. J Biol Chem 2003; 278:37926-36.
25. + T cells. J Immunol 2001; 166:5250-7.
26. Ruff AL, Guamieri FG, Staveley-O'Carroll KF, Siliciano RF, August JT. The enhanced immune response to the HIV gp160/ LAMP chimeric gene product targeted to the lysosome membrane protein trafficking pathway. Proc Natl Acad Sci USA 1997; 272:8671-8.
27. Nair SK, Boczkowski D, Morse M, Cumming RI, Lyerly HK, Gilboa E. Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA. Nat Biotechnol 1998; 16:364-9.
28. Su Z, Vieweg J, Weizer AZ et al. Enhanced induction of telomerase-specific CD4(+) T cells using dendritic cells transfected with RNA encoding a chimeric gene product. Cancer Res 2002; 62:5041-8.
29. Wu T, Guarnieri F, Staveley-O'Carroll K et al. Engineering an intracellular pathway for major histocompatibility complex class II presentation of antigens. Proc Natl Acad Sci USA 1995; 92:11671-5.
30. Rowell JF, Ruff AL, Guarnieri FG, Staveley-O'Carroll K, Lin X, Tang J, August IT, Siliciano RF. Lysosome-associated membrane protein-1-mediated targeting of the HIV-1 envelope protein to an endosomal/lysosomal compartment enhances its presentation to MHC class II-restricted T cells. J Immunol 1995; 155:1818-28.
31. Lin K, Guamieri F, Staveley-O'Carroll K, Levitsky H, August JT, Pardoll D, Wu T. Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen. Cancer Res 1996; 56:21-6.
32. Klein MR, Vanbaalen CA, Holwerda AM et al. Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics. J Exp Med 1995; 181:1365-72.
33. Musey L, Hughes J, Schacker T, Shea T, Corey L, McElrath MJ. Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection. N Engl J Med 1997; 337:1267-74.
34. + T cell responses associated with control of viremia. Science 1997; 278:1447-50.
35. + cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J Virol 1994; 68:6103-10.
36. Koup RA, Safrit JT, Cao Y, Andrews CA, McLeod G, Borkowsky W, Farthing C, Ho DD. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol 1994; 68: 4650-5.
37. + lymphocytes. Science 1999; 283:857-60.
38. Rowland-Jones S, Sutton J, Ariyoshi K et al. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women. Nat Med 1995; 1:59-64.
39. Rowland-Jones SL, Dong T, Dorrell L et al. Broadly cross-reactive HIV-specific cytotoxic T-lymphocytes in highly-exposed persistently seronegative donors. Immunol Lett 1999; 66:9-14.
40. Rowland-Jones S. Long-term, non-progression in HIV infection: clinico pathological issues. J Infect 1999; 38:67-70.
41. Ogg GS, Jin X, Bonhoeffer S et al. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science 1998; 279:2103-6.
42. + T cells produce antiviral cytokines but are impaired in cytolytic function. J Exp Med 2000; 192:63-75.
43. Kessler PD, Podsakoff GM, Chen X, McQuiston SA, Colosi PC, Matelis LA, Kurtzman GJ, Byrne BJ. Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein. Proc Natl Acad Sci USA 1996; 93:14082-7.
44. d through interactions between a glutamine at P3 and pocket D. J Immunol 1998; 161:2985-93.
45. Schirmbeck R, Reimann J. Alternative processing of endogenous or exogenous antigens extends the immunogenic, H-2 class I-restricted peptide repertoire. Mol Immunol 2002; 39:249-59.
46. Jondal M, Schirmbeck R, Reimann J. MHC class I-restricted CTL responses to exogenous antigens. Immunity 1996; 5:295-302.
47. Carbone FR, Kurts C, Bennett SR, Miller JF, Heath WR. Cross-presentation: a general mechanism for CTL immunity and tolerance. Immunol Today 1998; 19:368-73.
48. Norbury CC, Chambers BJ, Prescott AR, Ljunggren HG, Watts C. Constitutive macropinocytosis allows TAP-dependent major histocompatibility complex class I presentation of exogenous soluble antigen by bone marrow-derived dendritic cells. Eur J Immunol 1997; 27:280-8.
49. Castellino F, Boucher PE, Eichelberg K, Mayhew M, Rothman JE, Houghton AN, Germain RN. Receptor-mediated uptake of antigen/ heat shock protein complexes results in major histocompatibility complex class I antigen presentation via two distinct processing pathways. J Exp Med 2000; 191:1957-64.
50. Gromme M, Uytdehaag FG, Janssen H et al. Recycling MHC class I molecules and endosomal peptide loading. Proc Natl Acad Sci USA 1999; 96:10326-31.
51. Heath WR, Carbone FR. Cytotoxic T lymphocyte activation by cross-priming. Curr Opin Immunol 1999; 11:314-8.
52. Heath WR, Carbone FR. Cross-presentation, dendritic cells, tolerance and immunity. Annu Rev Immunol 2001; 19:47-64.
53. Heath WR, Carbone FR. Cross-presentation in viral immunity and self-tolerance. Nat Rev Immunol 2001; 1:126-34.
54. Delamarre L, Holcombe H, Mellman I. Presentation of exogenous antigens on major histocompatibility complex (MHC) class I and MHC class II molecules is differentially regulated during dendritic cell maturation. J Exp Med 2003; 198:111-22.
55. Oehen S, Junt T, Lopez-Macias C, Kramps TA. Antiviral protection after DNA vaccination is short lived and not enhanced by CpG DNA. Immunology 2000; 99:163-9.
56. + T cells by DNA vaccination depends on appropriate targeting of sufficient levels of immunologically relevant antigen to appropriate processing pathways. J Immunol 2002; 169:4951-60.
57. Schluns KS, Lefrancois L. Cytokine control of memory T-cell development and survival. Nat Rev Immunol 2003; 3:269-79.
58. Jaleco S, Swainson L, Dardalhon V, Burjanadze M, Kinet S, Taylor N. Homeostasis of naive and memory CD4(+) T cells: IL-2 and IL-7 differentially regulate the balance between proliferation and Fas-mediated apoptosis. J Immunol 2003; 171:61-8.
59. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, Pulendran B, Palucka K. Immunobiology of dendritic cells. Annu Rev Immunol 2000; 18:767-811.
60. Guermonprez P, Valladeau J, Zitvogel L, Thery C, Amigorena S. Antigen presentation and T cell stimulation by dendritic cells. Annu Rev Immunol 2002; 20:621-67.
61. Watts C. Capture and processing of exogenous antigens for presentation on MHC molecules. Annu Rev Immunol 1997; 15:821-50.
62. Rosenberg ES, Altfeld M, Poon SH et al. Immune control of HIV-1 after early treatment of acute infection. Nature 2000; 407:523-6.